ES369537A1 - Procedimiento para la preparacion de nuevos 1-fenoxi-2 - hidroxi-3-alhocilaminopropanos sustituidos, racemicos u op- ticamente activos. - Google Patents

Procedimiento para la preparacion de nuevos 1-fenoxi-2 - hidroxi-3-alhocilaminopropanos sustituidos, racemicos u op- ticamente activos.

Info

Publication number
ES369537A1
ES369537A1 ES369537A ES369537A ES369537A1 ES 369537 A1 ES369537 A1 ES 369537A1 ES 369537 A ES369537 A ES 369537A ES 369537 A ES369537 A ES 369537A ES 369537 A1 ES369537 A1 ES 369537A1
Authority
ES
Spain
Prior art keywords
formula
compound
racemic
preparation
optically active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES369537A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CH Boehringer Sohn AG and Co KG
Original Assignee
CH Boehringer Sohn AG and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CH Boehringer Sohn AG and Co KG filed Critical CH Boehringer Sohn AG and Co KG
Publication of ES369537A1 publication Critical patent/ES369537A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ES369537A 1967-02-06 1969-07-15 Procedimiento para la preparacion de nuevos 1-fenoxi-2 - hidroxi-3-alhocilaminopropanos sustituidos, racemicos u op- ticamente activos. Expired ES369537A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DEB0091070 1967-02-06

Publications (1)

Publication Number Publication Date
ES369537A1 true ES369537A1 (es) 1971-06-01

Family

ID=6985633

Family Applications (9)

Application Number Title Priority Date Filing Date
ES349847A Expired ES349847A1 (es) 1967-02-06 1968-01-27 Procedimiento para la preparacion de nuevos 1-fenoxi-2hi- droxi-3-alcohilamonopropanos sustituidos, racemicos u opti- camente activos.
ES369541A Expired ES369541A1 (es) 1967-02-06 1969-07-15 Procedimiento para la preparacion de nuevos 1 - fenoxi-2- hidroxi-3-alcohilaminopropanos sustituidos, racemicos u op- ticamente activos.
ES69369543A Expired ES369543A1 (es) 1967-02-06 1969-07-15 Procedimiento para la preparacion de nuevos 1-fenoxi-2-hi- droxi - 3-alcohilaminopropanos sustituidos, racemicos u op- ticamente activos.
ES369538A Expired ES369538A1 (es) 1967-02-06 1969-07-15 Procedimiento para la preparacion de nuevos 1-fenoxi-2-hi- droxi-3 - alcohilaminopropanos sustituidos, racemicos u op- ticamente activos.
ES369537A Expired ES369537A1 (es) 1967-02-06 1969-07-15 Procedimiento para la preparacion de nuevos 1-fenoxi-2 - hidroxi-3-alhocilaminopropanos sustituidos, racemicos u op- ticamente activos.
ES369540A Expired ES369540A1 (es) 1967-02-06 1969-07-15 Procedimiento para la preparacion de nuevos 1-fenoxi-2-hi- droxi - 3-alcohilaminopropanos sustituidos, racericos u op- ticamente activos.
ES69369544A Expired ES369544A1 (es) 1967-02-06 1969-07-15 Un procedimiento para la preparacion de nuevos 1-fenixi-2- hidroxi-3- alcohilaminopropanos sustituidos, racemicos u op-ticamente activos.
ES369542A Expired ES369542A1 (es) 1967-02-06 1969-07-15 Procedimiento para la preparacion de nuevos 1 - fenoxi - 2 - hidroxi - 3 - alcohilaminopropanos sustituidos, racemicos u opticamente activos.
ES369539A Expired ES369539A1 (es) 1967-02-06 1969-07-15 Procedimiento para la preparacion de nuevos 1 - fenoxi-2- hidroxi-3-alcohilaminopropanos sustituidos, racemicos u op- ticamente activos.

Family Applications Before (4)

Application Number Title Priority Date Filing Date
ES349847A Expired ES349847A1 (es) 1967-02-06 1968-01-27 Procedimiento para la preparacion de nuevos 1-fenoxi-2hi- droxi-3-alcohilamonopropanos sustituidos, racemicos u opti- camente activos.
ES369541A Expired ES369541A1 (es) 1967-02-06 1969-07-15 Procedimiento para la preparacion de nuevos 1 - fenoxi-2- hidroxi-3-alcohilaminopropanos sustituidos, racemicos u op- ticamente activos.
ES69369543A Expired ES369543A1 (es) 1967-02-06 1969-07-15 Procedimiento para la preparacion de nuevos 1-fenoxi-2-hi- droxi - 3-alcohilaminopropanos sustituidos, racemicos u op- ticamente activos.
ES369538A Expired ES369538A1 (es) 1967-02-06 1969-07-15 Procedimiento para la preparacion de nuevos 1-fenoxi-2-hi- droxi-3 - alcohilaminopropanos sustituidos, racemicos u op- ticamente activos.

Family Applications After (4)

Application Number Title Priority Date Filing Date
ES369540A Expired ES369540A1 (es) 1967-02-06 1969-07-15 Procedimiento para la preparacion de nuevos 1-fenoxi-2-hi- droxi - 3-alcohilaminopropanos sustituidos, racericos u op- ticamente activos.
ES69369544A Expired ES369544A1 (es) 1967-02-06 1969-07-15 Un procedimiento para la preparacion de nuevos 1-fenixi-2- hidroxi-3- alcohilaminopropanos sustituidos, racemicos u op-ticamente activos.
ES369542A Expired ES369542A1 (es) 1967-02-06 1969-07-15 Procedimiento para la preparacion de nuevos 1 - fenoxi - 2 - hidroxi - 3 - alcohilaminopropanos sustituidos, racemicos u opticamente activos.
ES369539A Expired ES369539A1 (es) 1967-02-06 1969-07-15 Procedimiento para la preparacion de nuevos 1 - fenoxi-2- hidroxi-3-alcohilaminopropanos sustituidos, racemicos u op- ticamente activos.

Country Status (13)

Country Link
BE (1) BE710400A (es)
BG (2) BG15028A3 (es)
CH (10) CH510631A (es)
DE (1) DE1593762A1 (es)
ES (9) ES349847A1 (es)
FI (1) FI49496C (es)
FR (2) FR1566349A (es)
GB (1) GB1227480A (es)
IE (1) IE32353B1 (es)
IL (1) IL29416A (es)
NL (2) NL139236B (es)
SE (1) SE359292B (es)
YU (4) YU32762B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA945172A (en) * 1969-02-21 1974-04-09 Imperial Chemical Industries Limited Alkanolamine derivatives
JPS4875539A (es) * 1972-01-12 1973-10-11
JPS49245A (es) * 1972-04-17 1974-01-05
DE2839475A1 (de) * 1978-09-11 1980-03-20 Dolorgiet Arzneimittelfabrik Isopropylamin-verbindungen, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
US4454154A (en) * 1981-06-23 1984-06-12 American Hospital Supply Corporation Method for treating glaucoma by the topical administration of selectively metabolized beta-blocking agents
DE3407695A1 (de) * 1984-03-02 1985-09-12 Röhm Pharma GmbH, 6108 Weiterstadt Pteridinverbindungen mit pharmazeutischer wirksamkeit
US4665094A (en) * 1985-08-29 1987-05-12 Merck & Co., Inc. Oculoselective beta-blockers for treatment of elevated intraocular pressure

Also Published As

Publication number Publication date
ES369543A1 (es) 1971-06-01
NL139236B (nl) 1973-07-16
FI49496B (es) 1975-04-01
YU32701B (en) 1975-06-30
YU32762B (en) 1975-06-30
IE32353L (en) 1968-08-06
IE32353B1 (en) 1973-07-11
NL6801661A (es) 1968-08-07
CH521310A (de) 1972-04-15
ES369541A1 (es) 1971-04-01
YU149373A (en) 1974-12-31
CH510635A (de) 1971-07-31
BG15030A3 (bg) 1975-08-07
DE1593762A1 (de) 1972-06-08
YU149873A (en) 1974-12-31
SE359292B (es) 1973-08-27
ES369544A1 (es) 1971-06-01
ES369539A1 (es) 1971-04-01
BE710400A (es) 1968-08-06
CH510637A (de) 1971-07-31
NL7301803A (en) 1973-04-25
BG15028A3 (bg) 1975-05-15
YU25268A (en) 1974-12-31
CH510634A (de) 1971-07-31
CH510636A (de) 1971-07-31
CH510631A (de) 1971-07-31
CH511212A (de) 1971-08-15
ES349847A1 (es) 1970-04-16
FI49496C (fi) 1975-07-10
ES369542A1 (es) 1972-03-16
CH506482A (de) 1971-04-30
ES369538A1 (es) 1971-06-01
CH510633A (de) 1971-07-31
YU149473A (en) 1974-12-31
IL29416A (en) 1973-03-30
FR1566349A (es) 1969-05-09
YU32763B (en) 1975-06-30
GB1227480A (es) 1971-04-07
CH510632A (de) 1971-07-31
ES369540A1 (es) 1971-06-01
YU32761B (en) 1975-06-30
FR8040M (es) 1970-08-10

Similar Documents

Publication Publication Date Title
GB1200886A (en) Phenylaminoethanol derivatives
ES361724A1 (es) Un procedimiento para la preparacion de derivados de feni- letanolamina.
GB1260848A (en) Propanolamine derivatives
ES369538A1 (es) Procedimiento para la preparacion de nuevos 1-fenoxi-2-hi- droxi-3 - alcohilaminopropanos sustituidos, racemicos u op- ticamente activos.
GB1359871A (en) Amino propanol
GB1446781A (en) Pharmaceutical preparations comprising derivatives of phenyl propionic acid
GB1481813A (en) Substituted thiazolinylidenyl ketones and their pharmaceutical compositions
GB1188154A (en) New Pyridine Derivatives and process for their preparation
ES335340A1 (es) Un metodo de producir nuevas fenoxipropilaminas.
GB1246051A (en) Improvements in or relating to isoquinoline derivatives
ES388885A1 (es) Procedimiento para la preparacion de 1-(2-nitrilofenoxi)-2-hidroxi-3-etilaminopropano racemicos u opticamente activo.
GB1434805A (en) 5-phenoxy-4-amino pyrimidines
GB1474133A (en) Benzindole derivatives
GB1497161A (en) Naphthyl derivatives
GB1423954A (en) Thionothiol-phosphoric acid esters process for their preparation and their use as insecticides and acaricides
GB1353508A (en) Aminoisoquinolines
GB1307256A (en) Piperazine derivatives and a process for their preparation
GB1181520A (en) Substituted 1-Aminoadamantanes
GB1340407A (en) Phenylethanolamine derivatives
GB1388450A (en) Pyrazolylphenylalkylaminoalkyl-ketones
ES360460A1 (es) Un procedimiento de preparacion de nuevos compuestos hete- rociclicos.
GB1468079A (en) Ethanolamine derivatives
GB1264128A (es)
GB1222947A (en) Thiophene derivatives
ES356703A1 (es) Procedimiento para la obtencion de compuestos de accion co-ronariodilatadora y anti-arritmica.